Introduction
The terminology of oral lesions, which may have the potential to progress to malignancy has varied over the years. At a World Health Organisation (WHO) workshop in 2007, it was recommended that the distinction between potentially malignant lesions and conditions should be abandoned in favour of a common terminology of oral potentially malignant disorders (OPMD) (1,2) and this has now been accepted in the latest WHO classification (3).
The term OPMD recognises the fact that even in patients with a defined lesion, such as leukoplakia, malignancy may arise elsewhere in the oral cavity as a result of field change, even in clinically normal mucosa (4,5). There are a number of disorders which have been associated with an increased risk of squamous cell carcinoma, including leukoplakia, erythroplakia, oral lichen planus, oral submucous fibrosis, actinic cheilitis, palatal lesions of reverse cigar smoking, discoid lupus erythematosus, and some inherited disorders such as dyskeratosis congenita and Fanconi's anaemia. From a clinical perspective, the vast majority of lesions of concern present as white patches, with or without a speckled or red component, and many of these will not have a specific diagnosis and must be managed as leukoplakia.
Although these disorders have an increased statistical risk of malignant change, it is very difficult to predict the outcome for an individual patient. This review will focus on leukoplakia but other disorders will be mentioned where there is evidence of any defined risk factors.
The prognosis of oral potentially malignant disorders
The definition of leukoplakia remains unsatisfactory, but essentially it refers to a white lesion of the oral mucosa, that cannot be defined as a known disease or disorder and carries an increased risk of progressing to cancer (1-6). However, leukoplakia is a dynamic lesion which may vary in texture or colour over time, and is not always "white". Indeed, leukoplakias deemed to be at most risk are often speckled red and white lesions. Pure red lesions, or erythroplakia are much rarer, but have the greatest risk for malignant change (7). Although progression to cancer is the most important outcome, only relatively few lesions progress and the remainder may persist unchanged, may enlarge or reduce in size, or may even resolve completely. Features that may be associated with increased risk of progression to malignancy are listed in Table 1 , with our estimate of the strength of the association.
Explanatory notes and relevant references are found in the following sections.
Clinical prognostic factors for progression to cancer

Site
The location of a lesion within the mouth may influence the risk of malignant transformation, but this is almost certainly related to aetiological factors and therefore may vary by geographical location and local habits. For example, in betel quid chewers the buccal mucosa is likely to be the most affected site, while in the developed world where smoked tobacco and alcohol are the most important aetiological factors, the floor of the mouth and lateral border of the tongue, are the most common sites for OPMD and oral cancer. In a UK study of 630 patients with dysplastic lesions, over 95% were leukoplakias and the most common sites (42% of lesions) were the lateral and ventral tongue and floor of the mouth (8). In addition, lesions at these sites were more likely to show severe epithelial dysplasia.
Conversely, only 21% of lesions arose on the buccal mucosa, and these were mostly mild dysplasia. In a similar study in Australia, Dost et al (9) found that the buccal mucosa was the single most common site for OPMDs (31% of lesions in which 50% of these were OLP), but 40% were on the tongue and in the floor of the mouth. However, lesions on the tongue and floor of mouth were more likely to be dysplastic or malignant (OR. 2.6: p=0.005). It is noteworthy to recognise that ventral of tongue and floor of mouth are contiguous anatomic sites and some authors don't specify the exact location of a lesion on tongue surfaces. This may warrant a careful interpretation of the findings. In a cross-sectional study of 3,256 leukoplakias in the USA, the highest prevalence of severe dysplasia or carcinoma-in-situ was in the floor of mouth (13.5%) and tongue (5%) (10). These data suggest that these sites are at the highest risk, but studies of actual malignant transformation have shown variable findings.
In Hungary, although only 8.2% of leukoplakias arose on the tongue, these accounted for 37 .5% of lesions that underwent malignant transformation, equivalent to a transformation rate of 27% for tongue leukoplakias (11). Floor of mouth also had a high transformation rate with 13% of lesions developing into cancer. In contrast, although most of the leukoplakias (63%) were found on the buccal mucosa, only 4.0% of these lesions progressed (11).
Similar data have been reported in England, where two studies showed high transformation rates of 24% (12) and 16% (13) for leukoplakias in the floor of the mouth (sublingual keratosis).
In contrast, some studies have been unable to establish a strong correlation between site and malignant transformation. Schepman et al. (14) studied 101 patients with lesions on the tongue or floor of mouth and 15 (14.9%) developed oral cancer, compared to 5 of 65 (7.7%) whose lesions were located elsewhere, but this was not statistically significant. In a second study by Dost et al. (15) the malignant potential of 383 dysplastic lesions in 368 patients was determined. Although the tongue (48.8% of lesions) and floor of mouth (11.5%), together were the most common sites, and the tongue had the highest transformation rate of 1.4% per year, the relationship between site and transformation was not significant. Holmstrup et al. (16) followed 236 patients with 269 lesions, and found a malignant transformation rate of 12% for lesions treated surgically and 4% for lesions observed. The only significant prognostic factors were size and type of lesion (homogenous versus non-homogenous). The site of the lesions was not significant. In summary, most studies and clinical papers do emphasise the lateral and ventral tongue and floor of the mouth as areas of particular clinical concern, and this may be due to their over exposure to carcinogens due to pooling of saliva in alcohol and tobacco users (17) . In their systematic review, Warnakulasuriya and Ariyawardana (6) found that, on a global basis, the buccal mucosa was the most common site overall (18.4% of lesions), but had the lowest rate of malignant transformation (3.35%), whereas the tongue accounted for 16.14% of lesions, but was the most common site for transformation with a rate of 24.22%. The next most common site was the combined "tongue and floor of mouth" at a rate of 14.85%.
However, these data may hide some geographic variations since they may apply to populations with the most common habits of smoked tobacco and alcohol. In other populations other sites may be more important and be associated with specific tobacco habits. For example, in Andhra Pradesh 71% of leukoplakias were located on the palate associated with reverse smoking, and in Kerala, 65% were on the buccal mucosa, associated with chewed tobacco (18) .
Clinical appearance
Oral leukoplakia shows a variety of clinical appearances, and this had led to several definitions that were complicated and confusing Leukoplakias are uniformly white or plaquelike, with a flat or wrinkled surface that may contain fine cracks or fissures (homogenous leukoplakia) (Figure 1 ), while others are non-homogenous ( Figure 2 ) and may have a warty, nodular or verrucous surface pattern ("verrucous leukoplakia") or may contain red areas or be speckled ("speckled leukoplakia" or "erythroleukoplakia"). There is consensus in the literature that non-homogenous lesions have a greater risk of malignant transformation than homogenous lesions (2-6), but it can be very difficult to compare studies because of the different locations and different ways of reporting malignant transformation. For example most large Indian studies are population or community based, often involving house-tohouse surveys (18) , whereas most studies in the developed world are based on hospital populations or retrospective analyses of pathology records. However, a systematic review (19) found a global prevalence of leukoplakia of 2.6% and a malignant transformation rate of 1.36% per year. Warnakulasuriya and Ariyawardana (6) carried out a systematic review of 24 studies and found an overall malignant transformation rate of between 1.5% and 34.0%, but there was a wide variation in the location or type of study. They found 8 studies which compared homogenous and non-homogenous lesions, and all showed that nonhomogenous lesions had the highest rate of progression. In their summary analysis they calculated an overall transformation rate of 3.0% for homogenous lesions and 14.5% for non-homogenous lesions (p=0.001). One of the largest series was published by Bánóczy (11) who summarised a series of papers (20-23) on a cohort of 670 Hungarian patients.
Over a 30 year follow up period, 6% (40 cases) of leukoplakias progressed to cancer. They divided the lesions into three clinical variants: simplex (homogenous), and verrucous or erosive (speckled) (both non-homogenous). None of the homogenous lesions (simplex) progressed to cancer, whereas the transformation rate for verrucous lesions was 4.6% and for erosive was 28.0%. The overall rate for the non-homogenous group was 13.4%.
Expressing this data in a different way, there were 82 erosive lesions which accounted for 74% of the oral cancers. The remaining 26% arose from 173 verrucous lesions. Although the actual data may vary, Bánóczy's finding that verrucous and, especially, speckled lesions have the highest rates of progression have been confirmed a number of times. In the largest Indian study to date (18) the overall malignant transformation rates were very low (0.3% -2.19%) but homogenous lesions were much less likely to become malignant. In California, Silverman (24) showed that non-homogenous lesions (erythroleukoplakia) transformed in 23.4% of cases compared to 6.5% of homogenous lesions. In a series of Norwegian patients (25), 14 of 157 patients with leukoplakia developed cancer, but only one of these arose in a homogenous lesion (1.6%) while the remainder arose from non-homogenous lesions (13 from 97; 13.4%). Of these, 28 were described as nodular and 8 became malignant (28.6%).
In Holmstrup et al's study (16) , non-homogenous lesions showed a seven times increased risk of progression to cancer when compared to homogenous lesions (OR= 7.0; 95% CI, 1.7,28.5). Of all the factors which they analysed, the type of lesion was the most significant in predicting prognosis. A characteristic type of non-homogenous leukoplakia -proliferative verrucous leukoplakia -has been described and is discussed below.
The use of the terms homogenous and non-homogenous leukoplakia has been severely criticised since it may over-emphasise the importance of white lesions and divert clinicians' attention away from the more significant and dangerous red lesions (26) . As noted above, the highest rates of malignant change were noted in lesions which were described as speckled or erosive (11) or as erythroleukoplakia (24) -in other words, emphasising that these lesions are not in fact true "leukoplakias" (white plaques) but have a red component.
The seminal work of Mashberg is well known and although he did not primarily study OPMDs, his work shows that most early oral cancers are red or have a significant red component (erythroplasia) (27, 28) . In his first major study on this subject (27) Mashberg identified 158 asymptomatic, early lesions in 125 patients. One hundred and twelve lesions were invasive squamous cell carcinomas and 46 were carcinoma-in-situ. His major finding, which formed the basis of his later work and opinions (26, 28) was that over 90% of the lesions had a red component and only 14 (9%) were described as white (of which 9 presented on the lips). Sixty lesions (38%) were entirely red and a further 98 (62%) were red and white (speckled, stippled or patchy). In later studies (reviewed in 28) he confirmed these findings in a cohort of 236 asymptomatic cancers, of which only 6% were white. The remainder were entirely red (32%), had a predominant red component (32%) or were mixed (29%). In his reviews (26, 28) he emphasises the importance of redness as an early sign of cancer and expresses dismay at the over-emphasis of "leukoplakia" as a premalignant condition, which, he claims, is a major cause of the lack of progress in early diagnosis of cancer.
Erythroplakia is a well defined clinical lesion (3,7) but Mashberg is correct in that it is often not included in studies of OPMD (eg. 4,6,10,11,17) -probably because it is relatively uncommon and therefore more difficult to study. In their survey of 50,915 Indians, Mehta et al. (29) found 881 leukoplakias (1.73%) but there were only 9 cases of erythroplakia (0.02%) (7). In the USA, only 58 cases were identified among 64,345 biopsy samples (0.09%) (30) .
Reichart and Phillipsen (7) reviewed a number of population studies which showed a prevalence of between 0.02% and 0.83%. As suggested by Mashberg (26, 28) , the majority of erthroplakias, show invasive carcinoma or carcinoma-in-situ, so the issue of progression to malignancy is a moot point, since the lesion should probably be managed as malignant at first presentation. In Shafer and Waldron's series of 58 cases (30) 51% showed invasive cancer and 40% showed severe epithelial dysplasia or carcinoma-in-situ at first biopsy. The remaining 9% showed mild or moderate dysplasia. For erythroplakias that do not show invasive cancer at first biopsy, the majority will show high risk histological features. The best estimates for malignant progression of these lesions can be derived from data for the malignant transformation of lesions showing severe epithelial dysplasia (including carcinoma-in-situ). A number of relevant studies are summarised in Table 2 .
Size
In Holmstrup et al's. study (16) size was the only other factor which showed a statistical correlation with malignant transformation. Specifically, lesions greater then 200mm 2 were more likely to progress than lesions less than this size (OR=5.4; 95% CI, 1.1,26.1). In a study of 50 patients from Northern Ireland, Napier et al. (37) , found that the risk of transformation was 6 times greater in patients with large confluent lesions that extended over more than one anatomical site compared to smaller localised lesions. Of 12 patients with such lesions, 7 developed oral cancer. They also found 11 patients with lesions at one anatomical site, five of whom developed cancer, a risk 4 times greater than in those with multiple lesions. It was notable that of the 27 patients with multiple non-confluent lesions, only 5 progressed to malignancy. Warnakulasuriya and Ariyawardana (6) recommended on the evidence from their systematic review that any leukoplakia that exceeds 200mm 2 has a higher risk for malignant transformation.
Age/duration
Most studies agree that although OPMDs are chronic and persistent, the risk of malignant change is higher within the first five years after diagnosis. In their systematic review, Warnakulasuriya and Ariyawardana (6) found 5 studies that had analysed transformation by age groups. Overall, although lesions tended to progress early in their natural history, transformation rates were higher in older individuals. In a large Swedish study, involving 782 patients with leukoplakia, the highest transformation rate (6.4% in five years) was found in those aged 70-89 years, compared to less than 1% in all age groups below 50 years (38) . In
Bánóczy's Hungarian series (11) the peak incidence of leukoplakia was in the sixth decade, but the highest rates of transformation were in the seventh decade (7.1%) or in patients over 71 (8.2%). They also noted however a transformation rate of 7.4% in the fourth decade. In his series of 157 Norwegian patients with leukoplakia, Lind (25) found that lesions tended to progress soon after first diagnosis. Of the 14 cases which progressed, 5 patients developed oral cancer in the first year and six within the next eight years. In the Netherlands, it was noted that the number of transformed lesions increased with longer follow-up times (14) .
They estimated that 50% of patients with leukoplakia would develop a tumour within 200 months of diagnosis, but the median time to malignant transformation was only 32 months.
They found that overall, 12.4% of lesions transformed and that the mean age of first presentation of the patients who developed cancer was 67.1 years, compared to 55.8 years for patients who did not develop cancer.
The large studies from India and the developing world support the view that lesions are likely to develop and progress in older individuals since the highest incidences of leukoplakia are consistently in younger age groups than oral cancer (18, 29, 39, 40) . For example, the highest incidence of leukoplakia in Kerala was found in 35-54 year olds while the highest incidence of oral cancer was in the 55-74 year age group (40).
Gender
Warnakulasuriya and Ariyawardana's review (6) identified 12 studies that had looked at gender and malignant transformation. In nine of the twelve studies, the rate of transformation was greater in females than males, with an overall rate of 13.1% for females and 1.7% for males (p<0.001). The highest rate in females was 40.6%, reported from
Northern Ireland (37) and the lowest was found in Denmark (3.7%) (41) . In males the highest rate was 28.6% in the United Kingdom (13) and the lowest was 0% in the Netherlands (42) .
Another study in the Netherlands however, found 76 males with leukoplakia of whom 4 developed oral cancer (5.3%), but of 90 females with lesions 16 females progressed (17.7%) (14) . In a Norwegian study, Lind (25) found lesions in 102 males and 55 females, but oral cancer developed in 8 males (7.8%) and six females (10.9%). Nonetheless, it is still unclear why women are more predisposed to malignant transformation than men. Global genomic arrays may illustrate a differential gene expression that explains this gender predilection.
The propensity for females to have a higher risk of malignant transformation is despite the fact that lesions are less common in females. In Sweden, Axell (43) found a male:female ratio of 6:1, but this reduced to 5:2 among non-smokers. In the USA the male:female ratio was reported as 2:1 (44). In the large Indian studies (18, 29, 39, 40, 45) females were much less likely to have lesions, but this was related to the fact that they were less likely to use tobacco.
Habits
Tobacco use and consumption of alcohol are well established aetiological factors for the development of OPMD, but there is also good evidence that risk of progression is related to the use of, or continued use of, these habits. Lesions in non-smokers (sometimes referred to as "idiopathic leukoplakia") seem to be at a higher risk of progression to cancer (17) . In
Schepman's study in the Netherlands (14) the three factors associated with the greatest risk of transformation, were non-homogenous lesions (p=0.01), being female (p<0.025) and female non-smokers (p<0.05). There were no statistically significant associations with smoking in males, nor for alcohol in either gender. In another study in the Netherlands (42) patients stopped smoking after diagnosis and among these, 6 (12%) developed oral cancer, and in a further 22 (44%) lesions became smaller or resolved. In a Swedish study (38) , the cumulative frequency of oral cancer development was 3.1% over 5 years in non-tobacco users compared to only 0.4% in smokers. In her large Hungarian studies, Bánóczy (11) found that the proportion of patients who smoked was higher in those with leukoplakia that did not progress (87%) than in those who developed carcinoma (78%) and concluded that there was a greater tendency for malignant transformation in leukoplakias not associated with tobacco. In a study in England, Ho et al. (46) found that the most significant predictor of malignant change was non-smoking status. They studied 91 patients with histologically diagnosed dysplasia, of whom 20 were never-smokers, 29 moderate smokers and 42 were heavy smokers. After 5 years of follow up, 13 never smokers (43%) developed cancer compared to 11% and 4% respectively in the other two groups (p=0.001).
These data suggest that although tobacco is an important aetiological factor for the formation of keratotic lesions, other factors must be important for these lesions to progress to malignancy. The increased risk in non-smokers suggests that an underlying genetic predisposition may also be involved in at least a proportion of cases. It should be noted however, that not all studies have been able to demonstrate a relationship between tobacco use and progression. Warnakulasuriya and Ariyawardana (6) did not identify any papers which analysed smoking as a factor, and neither Dost et al. (9) nor Holmstrup et al. (16) found any significant associations between smoking and progression to malignancy. With regards to alcohol, there is much evidence to implicate it as an aetiological factor, but no evidence for a role as a risk factor for progression in established lesions (4,6,9,17,47). The use of betel quid and areca nut are also risk factors, and are considered below under oral submucous fibrosis.
Histological prognostic factors for progression to cancer
Epithelial dysplasia
Although it is established that OPMD are statistically more likely to become malignant, it is not inevitable that each lesion will progress to cancer. Although the clinical parameters described above may help in clinical risk assessment, the gold standard diagnostic procedure is to undertake a biopsy for histological examination. This will enable the pathologist to exclude any specific diagnosis, and to evaluate any tissue changes, the most significant of which are features of cytological atypia and distorted epithelial architecture, which together are referred to as oral epithelial dysplasia (OED) (2,3). It is not inevitable however, that a dysplastic lesion will transform into cancer, and non-dysplastic lesions may also progress. Silverman et al. (24) showed that 36% of dysplastic lesions progressed to carcinoma, but also that 16% of leukoplakic lesions without evidence of dysplasia progressed. Clinical or histological biomarkers are desperately needed to improve our ability to distinguish lesions that may progress from those that will not (2,48), but, given the complexity of the oral carcinogenesis process and the lack of any proven predictive biomarkers in large prospective cohorts, surgical biopsy and histopathological grading of OED is regarded as the gold standard in managing these patients (2-5,49,50).
Historically, several terms including dyskeratosis, epithelial atypia, squamous intraepithelial neoplasia (SIN) or squamous intraepithelial lesions (SILs) have been used to describe epithelial changes that precede development of oral cancer. However, for lesions of the oral cavity, OED is still currently regarded as the preferred terminology (1-3,49). The latest 2017
WHO classification system (3) uses a combination of architectural and cytological features (Table 3) in an attempt to provide a more objective approach to the diagnosis and grading of OED. Pathologists should use these criteria to grade lesions, but several grading systems have been developed and there is, as yet, no international consensus as to which should be used (2,3). A major problem, is that the process of grading is subjective and has low levels of intra-and inter-observer agreement (2,15,51-53). Many pathologists grade lesions into mild, moderate, and severe dysplasia based on the extent and degree of the changes listed in Table 3 resection of all OED cases is warranted will not be discussed here, given that this topic is beyond the scope of our review and has been well reviewed by others (5,16,50,59).
As it stands, grading of OED is still the most important prognostic factor for malignant transformation (2-4). However, even for severe epithelial dysplasia studies have shown that the malignant transformation rate varies considerably, from 3% to 50% (Table 2 ), and appears to be heavily dependent on the study design and population characteristics (17) . may have a better prognostic value and superior reproducibility than the currently more widely used three scale grading system (3). With further evaluations, it is believed that a binary system will become the standard grading scheme (2,3). There is also good evidence that the accuracy and prognostic reliability of dysplasia grading can be improved by careful training and by consensus reporting by at least two pathologists (2,3,55,65,66).
Several studies however, have not been able to find a relationship between epithelial dysplasia and malignant progression. Warnakulasuriya and Ariyawardana (6) found 5 papers which had correlated OED grade to malignant transformation, only 3 of which found a significant relationship (14, 46, 62) . Others have not been able to find a statistical correlation and have shown that non-dysplastic or low-grade lesions may also progress (15, 16, 24, 63) .
This contradicts the view that leukoplakic lesions without dysplasia, or mildly dysplastic lesions are entirely harmless, and has led to calls to drop the "wait and see" approach and for more active surgical intervention in the management of OPMDs (15, 16, 59 ).
Despite these uncertainties, the majority of the literature supports the view that OED carries a significant risk for malignant transformation and that it must be considered in the process of managing the clinical risk of progression of OPMDs. However, clinicians should acknowledge that pathologists report on the tissue they receive and that the histopathological findings are highly dependent on correct and representative sampling of Similarly, a possible association with Hepatitis C virus has also been reported (92,93,102).
However, it remains unclear whether the presence of infection is related to colonisation due to change in mucosal surface or if the virus plays an active role in OLP pathogenesis and progression to cancer. They suggested that DNA ploidy analysis may be useful to aid prediction of malignant transformation in a proportion of case.
Taken together, these data provide some evidence that patients with lichen planus may be at greater risk of developing oral cancer, but more precise and internationally agreed criteria for diagnosis need to be established. Risk factors for malignant transformation that have been shown to be statistically significant include smoking and alcohol use, and infection with HCV. Erosive lesions, lesions on the tongue and the presence of aneuploidy may also be associated with progression.
Oral submucous fibrosis
Oral submucous fibrosis (OSF) is a chronic disorder of the oral and pharyngeal mucosa characterised by fibrosis of the submucosa resulting in stiffness, limited opening and atrophy and whitening of the oral epithelium. Although often thought to have a complex multifactorial aetiology it is now recognised that OSF is directly associated with use of areca nut (104) (105) (106) and is predominantly seen among the populations of South and South East Asia or in Asian populations within the UK, USA and other developed countries (104) . However, only 1% -2% of areca nut users develop the disease suggesting that genetic predisposing factors are also involved (104) (105) (106) . The importance of OSF as a potentially malignant disorder was first recognised in 1956 (107) and since there have been numerous studies to determine the risk of progression. An early long-term follow-up study in India followed 99 patients with OSF for 17 years, and found a transformation rate of 7.6% (108). However, this was a small study and more recent larger studies have suggested a lower rate. In a recent review, Ray et al. (109) found that the transformation rate varied from 1.9% to 7.6%. Lesions may also resolve after antifungal therapy, suggesting that lesions that are primarily caused by Candida infection are not potentially malignant. Conversely, there is a significant association between fungal infection and the presence of epithelial dysplasia (115, 116) , but the debate regarding causation or association has not been resolved. Barrett et al. (116) reviewed 4724 mucosal biopsies and found evidence of PAS-positive fungal hyphae in 223 (4.7%). There was a significant association between fungal infection and squamous papilloma, median rhomboid glossitis and epithelia dysplasia (p<0.01). In particular, moderate and severe epithelial dysplasia were infected in 18.0% and 15.2% of cases respectively, with lesions on the tongue being most frequently infected. They also showed that dysplastic lesions, which were infected with candida, were almost three times more likely to show a higher grade of dysplasia in a subsequent biopsy, suggesting a positive correlation between Candida and progression of dysplasia. There is also some biological evidence that candida may be directly involved in carcinogenesis. This includes the finding that Candida isolated from leukoplakic lesions may produce carcinogenic nitrosamines (117) or acetaldehydes (118) and that Candida albicans can act as a promoter in a mouse model of 4NQO induced cancer (119). Despite this, it has not been possible to show a true causal relationship between Candida and epithelial dysplasia and cancer. Two in-depth reviews 
An approach to clinical risk assessment
Assessing the risk of malignant change in OPMDs can be difficult, since any decision at each stage of the management pathway is not binary, and the clinician may be faced with a number of options. The process of undertaking a clinical assessment can be considered in three stages -clinical history, clinical examination, and surgical biopsy and histopathological evaluation. In Figure 3 we have attempted to graphically indicate the features encountered at each stage that may be associated with risk. The starting point is identification of a suspicious lesion, which for this purpose we define as a lesion which cannot be diagnosed as a specific disorder on clinical examination. Specific lesions such as lichen planus or OSF have defined risks, and are not illustrated (see text). In Figure 3 , the features encountered at each stage are given a risk profile, green, amber or red, indicating low, medium or high risk respectively. For example, the history is the first stage of clinical assessment and here, female non-smokers would be regarded as at a higher risk than males. At clinical examination, erythroplakia has a higher risk that leukoplakia, but non-homogenous lesions have a higher risk than homogenous lesions, and speckled lesions are at a higher risk than verrucous lesions. Histopathological evaluation is a paramount and will be considered a critical in making informed decision about OPMD's management. Nonetheless, a holistic approach that combines the three stages of evaluation is essential to have the optimal outcomes of risk assessment of OPMDs.
Figure 1
Homogenous leukoplakia on right lateral border of tongue; a biopsy showedmild epithelial dysplasia.
Figure 2
Non-homogenous leukoplakia on the lateral border of the tongue. The lesion shows irregular red and white areas and may be termed "speckled leucoplakia". Histologic examination showed severe epithelial dysplasia. 
